These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 17425725

  • 1. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, Miyamoto A, Takeda Y, Umeshita K, Monden M.
    Transpl Int; 2007 Jul; 20(7):576-82. PubMed ID: 17425725
    [Abstract] [Full Text] [Related]

  • 2. Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
    Marubashi S, Dono K, Sugita Y, Asaoka T, Hama N, Gotoh K, Miyamoto A, Takeda Y, Nagano H, Umeshita K, Monden M.
    Transplant Proc; 2006 Dec; 38(10):3640-2. PubMed ID: 17175354
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M, Zhang Y, Zhong C, Lin XJ, Zhang CQ, Li JQ.
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [Abstract] [Full Text] [Related]

  • 4. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
    Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M.
    Hepatology; 2002 Apr; 35(4):853-60. PubMed ID: 11915031
    [Abstract] [Full Text] [Related]

  • 5. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS, Sheen IS, Tsai YC.
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [Abstract] [Full Text] [Related]

  • 6. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y, Song T, Meng L, Wu X, Ba Y, Li Q.
    ANZ J Surg; 2009 Aug; 79(1-2):62-9. PubMed ID: 19183381
    [Abstract] [Full Text] [Related]

  • 7. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS, Sheen IS, Tsai YC.
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [Abstract] [Full Text] [Related]

  • 8. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S.
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [Abstract] [Full Text] [Related]

  • 9. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
    Oya H, Sato Y, Yamamoto S, Nakatsuka H, Kobayashi T, Hara Y, Waguri N, Suda T, Aoyagi Y, Hatakeyama K.
    Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
    [Abstract] [Full Text] [Related]

  • 10. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
    Yang SZ, Dong JH, Zhu J, Li K, Zhang Y.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 09; 85(9):595-8. PubMed ID: 15949354
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.
    Marubashi S, Nagano H, Wada H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M.
    Ann Surg Oncol; 2011 Aug 09; 18(8):2200-9. PubMed ID: 21301972
    [Abstract] [Full Text] [Related]

  • 12. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
    Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ.
    Clin Cancer Res; 1999 Dec 09; 5(12):4021-7. PubMed ID: 10632334
    [Abstract] [Full Text] [Related]

  • 13. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK.
    Dig Dis; 2007 Dec 09; 25(4):313-9. PubMed ID: 17960066
    [Abstract] [Full Text] [Related]

  • 14. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
    Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M.
    Hepatology; 1997 Mar 09; 25(3):564-8. PubMed ID: 9049199
    [Abstract] [Full Text] [Related]

  • 15. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar 09; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 16. [Postoperative detection of AFP mRNA in the peripheral blood of hepatic cellular carcinoma patients and its correlation with recurrence].
    Zhi H, Zhan J, Deng QL, Huang ZM.
    Zhonghua Zhong Liu Za Zhi; 2007 Feb 09; 29(2):112-5. PubMed ID: 17645845
    [Abstract] [Full Text] [Related]

  • 17. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec 09; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H, Stemmer SM, Liberzon E, Avigad S, Sulkes J, Belinki A, Kazatsker A, Ben-Ari Z.
    Cancer Detect Prev; 2006 Dec 09; 30(2):204-9. PubMed ID: 16638626
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
    Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, Francoz C, Compagnon P, Vanlemmens C, Dumortier J, Dharancy S, Gugenheim J, Bernard PH, Adam R, Radenne S, Muscari F, Conti F, Hardwigsen J, Pageaux GP, Chazouillères O, Salame E, Hilleret MN, Lebray P, Abergel A, Debette-Gratien M, Kluger MD, Mallat A, Azoulay D, Cherqui D, Liver Transplantation French Study Group.
    Gastroenterology; 2012 Oct 09; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
    [Abstract] [Full Text] [Related]

  • 20. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
    Cheung ST, Fan ST, Lee YT, Chow JP, Ng IO, Fong DY, Lo CM.
    Transplantation; 2008 Jan 15; 85(1):81-7. PubMed ID: 18192916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.